IN186315B - - Google Patents

Info

Publication number
IN186315B
IN186315B IN2780DE1996A IN186315B IN 186315 B IN186315 B IN 186315B IN 2780DE1996 A IN2780DE1996 A IN 2780DE1996A IN 186315 B IN186315 B IN 186315B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Amarjit Singh
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Priority to IN2780DE1996 priority Critical patent/IN186315B/en
Priority to AU47627/97A priority patent/AU720132B2/en
Priority to US08/988,211 priority patent/US6017932A/en
Priority to KR1019970067689A priority patent/KR19980064024A/ko
Priority to JP9343471A priority patent/JPH10245337A/ja
Publication of IN186315B publication Critical patent/IN186315B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
IN2780DE1996 1996-12-12 1996-12-12 IN186315B (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IN2780DE1996 IN186315B (fr) 1996-12-12 1996-12-12
AU47627/97A AU720132B2 (en) 1996-12-12 1997-12-09 Pharmaceutical compositions
US08/988,211 US6017932A (en) 1996-12-12 1997-12-10 Pharmaceutical compositions containing at least one NSAID having increased bioavailability
KR1019970067689A KR19980064024A (ko) 1996-12-12 1997-12-11 약학 조성물
JP9343471A JPH10245337A (ja) 1996-12-12 1997-12-12 薬学的組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2780DE1996 IN186315B (fr) 1996-12-12 1996-12-12

Publications (1)

Publication Number Publication Date
IN186315B true IN186315B (fr) 2001-08-04

Family

ID=11092789

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2780DE1996 IN186315B (fr) 1996-12-12 1996-12-12

Country Status (5)

Country Link
US (1) US6017932A (fr)
JP (1) JPH10245337A (fr)
KR (1) KR19980064024A (fr)
AU (1) AU720132B2 (fr)
IN (1) IN186315B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289972B1 (it) * 1997-02-25 1998-10-19 Helsinn Healthcare Sa Formulazioni topiche di nimesulide in forma di sistemi a cristalli liquidi
IN188720B (fr) * 1997-11-06 2002-11-02 Panacea Biotec Ltd
AU718356B2 (en) * 1998-01-12 2000-04-13 Panacea Biotec Limited A parenteral water-miscible non-intensely coloured injectable composition of non-steroidal anit-inflammatory drugs
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
JP2002525311A (ja) * 1998-10-01 2002-08-13 エラン ファーマ インターナショナル，リミティド 徐放性ナノ粒子組成物
US8236352B2 (en) * 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US20090104273A1 (en) * 1999-06-22 2009-04-23 Elan Pharma International Ltd. Novel nifedipine compositions
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
ES2337547T3 (es) * 1999-09-28 2010-04-27 Panacea Biotec Limited Composiciones de liberacion controlada que contienen nimesulida.
US7105172B1 (en) * 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7198795B2 (en) * 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US7037524B2 (en) * 2001-10-03 2006-05-02 Herbalscience, Llc Oral delivery of a botanical
US20050069596A1 (en) * 2001-10-03 2005-03-31 Gow Robert T. Compositions and methods comprising kava and anti-anxiety compounds
US20050053678A1 (en) * 2001-10-03 2005-03-10 Gow Robert T. Methods and compositions for betel nut chewing gum
US7291352B2 (en) 2001-10-03 2007-11-06 Herbalscience Llc Methods and compositions for oral delivery of Areca and mate' or theobromine
US7714006B1 (en) 2001-12-03 2010-05-11 King Pharmaceuticals Research & Development, Inc. Methods of modifying the bioavailability of metaxalone
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
US20040101566A1 (en) * 2002-02-04 2004-05-27 Elan Pharma International Limited Novel benzoyl peroxide compositions
JP4598399B2 (ja) * 2002-02-04 2010-12-15 エラン ファーマ インターナショナル，リミティド 表面安定剤としてリゾチームを有するナノ粒子組成物
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
DE60309300T3 (de) * 2002-03-20 2011-02-24 Elan Pharma International Ltd. Nanopartikelzusammensetzungen von angiogeneseinhibitoren
WO2003084462A2 (fr) * 2002-04-04 2003-10-16 Modi, Indravadan Procede de preparation d'un composition pharmaceutique contenant un inhibiteur de protease antiretroviral ayant une biodisponibilite amelioree
KR100543180B1 (ko) * 2002-07-24 2006-01-20 주식회사 티지 바이오텍 혈소판 응집 억제활성이 우수한 알카로이드계 화합물
US20050037025A1 (en) * 2002-10-03 2005-02-17 Gow Robert T. Methods and compositions comprising kava and mate' or theobromine
AU2003202112A1 (en) * 2003-01-30 2004-08-23 Council Of Scientific And Industrial Research Bioavailability enhancing activity of carum carvi extracts and fractions thereof
WO2007122637A1 (fr) * 2006-04-24 2007-11-01 Panacea Biotec Ltd. Nouvelles compositions pharmaceutiques faiblement dosées contenant du nimésulide, leur préparation et utilisation
EP2011495A1 (fr) * 2007-07-03 2009-01-07 Sygnis Bioscience GmbH & Co. KG Utilisation de pipérine et dérivés correspondants pour la thérapie de conditions neurologiques
WO2011010214A1 (fr) * 2009-07-23 2011-01-27 Cadila Pharmaceuticals Ltd. Composition pharmaceutique de rifampicine
CN105748478B (zh) * 2016-04-08 2016-10-12 郭晓辉 一种治疗小儿腹泻的药物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248475B (it) * 1990-05-22 1995-01-19 Angeli Inst Spa Composti di inclusione di nimesulide con ciclodestrine
ES2023552A6 (es) * 1990-05-22 1992-01-16 Leetrim Limited Procedimiento para la preparacion de compuestos de inclusion de nimesulida con ciclodextrina.
IT1251838B (it) * 1991-09-20 1995-05-26 Lpb Ist Farm Uso della nimesulide nel trattamento della cataratta
HU210922B (en) * 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
EP0650728B1 (fr) * 1993-10-29 2002-02-27 Council of Scientific and Industrial Research Compositions pharmaceutiques contenant de la piperine et des medicaments antituberculeuse ou antiléprosique
IN176897B (fr) * 1993-10-29 1996-09-28 Cadila Lab Ltd
BE1008307A3 (fr) * 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.

Also Published As

Publication number Publication date
US6017932A (en) 2000-01-25
AU4762797A (en) 1998-06-18
KR19980064024A (ko) 1998-10-07
AU720132B2 (en) 2000-05-25
JPH10245337A (ja) 1998-09-14

Similar Documents

Publication Publication Date Title
IN190706B (fr)
IN186315B (fr)
IN191470B (fr)
IN182496B (fr)
ITMI960654V0 (fr)
ITMI960253A0 (fr)
ITFI960018A0 (fr)
ITMI960232A0 (fr)
ITMI960373A0 (fr)
ITMI960596V0 (fr)
IN192306B (fr)
IN192797B (fr)
ITLT960005A0 (fr)
ITGE960023V0 (fr)
CN3044346S (fr)
CN3047496S (fr)
CN3044348S (fr)
CN3044349S (fr)
CN3045208S (fr)
CN3047348S (fr)
CN3045806S (fr)
EP0855403A4 (fr)
EP0836082A4 (fr)
EP0789023A3 (fr)
CN3044168S (fr)